October 2016, Vol 7, No 9

Recent advances in the management of thyroid cancer have evolved directly from improved knowledge of the underlying genetics and molecular biology, an understanding that will continue to improve in the future, according to a recent review.

Read Article

Is Direct-to-Consumer Advertising for Cancer Drugs Beneficial to Patients?

By Jessica Miller

Health Policy, Policies & Guidelines

October 2016, Vol 7, No 9

Read Article

DCIS Score Not Cost-Effective in Selecting Patients for Adjuvant Radiation

By Wayne Kuznar

Value in Oncology

October 2016, Vol 7, No 9

Read Article

Hematologic Cancers Among the Most Costly Malignancies to Treat

By Alice Goodman

Hematologic Cancers, Value in Oncology

October 2016, Vol 7, No 9

Read Article

Value Assessments of Metastatic Colorectal Cancer Therapies Continue to Focus on Cost

By Charles Bankhead

Value in Oncology

October 2016, Vol 7, No 9

Read Article

Patient-Reported Outcomes Should Be Used Routinely in Cancer Care

By Chase Doyle

Palliative Care, Personalized Medicine

October 2016, Vol 7, No 9

Read Article

Death Rates Unaffected by Treatment Choice for Patients with Localized Prostate Cancer

By Alice Goodman

Prostate Cancer, Solid Tumors

October 2016, Vol 7, No 9

Read Article

Page 1 of 3

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

VBCC Print Edition

VBCC Weekly e‑Newsletter

October 2016, Vol 7, No 9

Top Trending Articles

Subscribe Today!

I'd like to receive:

Stay In The Know